Evaluation of horse urine sample preparation methods for metabolomics using LC coupled to HRMS

Bioanalysis

Volumn 6, Issue 6, 2014, Pages 785-803

  Stojiljkovic, Natali ^a,b   Paris, Alain ^c   Garcia, Patrice ^a   Popot, Marie Agnès ^a   Bonnaire, Yves ^a   Tabet, Jean Claude ^b   Junot, Christophe ^d  

^a Laboratoire des Courses Hippiques   (France)

^b Université Pierre et Marie Curie   (France)

^c AGROPARISTECH   (France)

^d CEA SACLAY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACETONITRILE; AMMONIUM SULFATE; ASPARTIC ACID; DRUG METABOLITE; MALONIC ACID; METFORMIN;

ARTICLE; BODY FLUID; CHEMICAL ANALYSIS; COMPARATIVE STUDY; DIELECTRIC CONSTANT; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HYDROLYSIS; IONIZATION; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; MEMBRANE FILTER; METABOLOME; METABOLOMICS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRINCIPAL COMPONENT ANALYSIS; SEPARATION TECHNIQUE; SIGNAL TRANSDUCTION; SOLID PHASE EXTRACTION; TEMPERATURE; URINALYSIS; VISCOSITY; ANIMAL; HORSE; PROCEDURES; URINE;

ANIMALS; CHROMATOGRAPHY, LIQUID; HORSES; METABOLOMICS;

EID: 84898737890     PISSN: 17576180     EISSN: 17576199     Source Type: Journal    
DOI: 10.4155/bio.13.324     Document Type: Article

References (59)

1. Mukhopadhyay R. Catching doping athletes. Anal. Chem. 79(15), 5522-5528 (2007).
2. Ho EN, Kwok WH, Leung DK, Wan TS, Wong AS. Metabolic studies of turinabol in horses. Anal. Chim. Acta 586(1-2), 208-216 (2007).
3. Leung GN, Tang FP, Wan TS, Wong CH, Lam KK, Stewart BD. In vitro and in vivo studies of androst-4-ene-3,6,17-trione in horses by gas chromatography-mass spectrometry. Biomed. Chromatogr. 24(7), 744-751 (2010).
4. Bailly-Chouriberry L, Pinel G, Garcia P, Popot MA, Le Bizec B, Bonnaire Y. Identification of recombinant equine growth hormone in horse plasma by LC-MS/MS: a confirmatory analysis in doping control. Anal. Chem. 80(21), 8340-8347 (2008).
5. Teale P, Scarth J, Hudson S. Impact of the emergence of designer drugs upon sports doping testing. Bioanalysis 4(1), 71-88 (2012).
6. Scarth JP, Clarke AD, Teale P, Pearce CM. Comparative in vitro metabolism of the 'designer' steroid estra-4,9-diene-3,17-dione between the equine, canine and human: identification of target metabolites for use in sports doping control. Steroids 75(10), 643-652 (2010).
7. Reichel C. OMICS-strategies and methods in the fight against doping. Forensic Sci. Int. 213(1-3), 20-34 (2011).
8. Dunn WB, Broadhurst D, Begley P et al. Procedures for large-scale metabolic profiling of serum and plasma using gas chromatography and liquid chromatography coupled to mass spectrometry. Nat. Protoc. 6(7), 1060-1083 (2011).
9. Baker M. Metabolomics: from small molecules to big ideas. Nat. Methods 8(2), 117-121 (2011).
10. Kiss A, Jacquet A-L, Paisse O et al. Urinary signature of anabolic steroids and glucocorticoids in humans by LC-MS. Talanta 83(5), 1769-1773 (2011).
11. Lindon JC, Nicholson JK. Analytical technologies for metabonomics and metabolomics, and multi-omic information recovery. Trends Analyt. Chem. 27(3), 194-204 (2008).
12. Gebregiworgis T, Powers R. Application of NMR metabolomics to search for human disease biomarkers. Comb. Chem. High Throughput Screen. 15(8), 595-610 (2012).
13. Werner E, Heilier JF, Ducruix C, Ezan E, Junot C, Tabet JC. Mass spectrometry for the identification of the discriminating signals from metabolomics: current status and future trends. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 871(2), 143-163 (2008).
14. Almstetter MF, Oefner PJ, Dettmer K. Comprehensive two-dimensional gas chromatography in metabolomics. Anal. Bioanal. Chem. 402(6), 1993-2013 (2012).
15. Theodoridis G, Gika HG, Wilson ID. LC-MS-based methodology for global metabolite profiling in metabonomics/metabolomics. Trends Analyt. Chem. 27(3), 251-260 (2008).
16. Ramautar R, Somsen GW, De Jong GJ. CE-MS in metabolomics. Electrophoresis 30(1), 276-291 (2009).
17. Vuckovic D. Current trends and challenges in sample preparation for global metabolomics using liquid chromatography-mass spectrometry. Anal Bioanal. Chem. 403(6), 1523-1548 (2012).
18. Thevis M, Geyer H, Sigmund G, Schanzer W. Sports drug testing: analytical aspects of selected cases of suspected, purported, and proven urine manipulation. J. Pharm. Biomed. Anal. 57, 26-32 (2012).
19. Álvarez-Sánchez B, Priego-Capote F, Luque de Castro MD. Metabolomics analysis II. Preparation of biological samples prior to detection. Trends Analyt. Chem. 29(2), 120-127 (2010).
20. Trufelli H, Palma P, Famiglini G, Cappiello A. An overview of matrix effects in liquid chromatography-mass spectrometry. Mass Spectrom. Rev. 30(3), 491-509 (2011).
21. Dams R, Huestis MA, Lambert WE, Murphy CM. Matrix effect in bio-analysis of illicit drugs with LC-MS/MS: influence of ionization type, sample preparation, and biofluid. J. Am. Soc. Mass Spectrom. 14(11), 1290-1294 (2003).
22. Taylor PJ. Matrix effects: the Achilles heel of quantitative high-performance liquid chromatography-electrospray-tandem mass spectrometry. Clin. Biochem. 38(4), 328-334 (2005).
23. Boyard-Kieken F, Dervilly-Pinel G, Garcia P et al. Comparison of different liquid chromatography stationary phases in LC-HRMS metabolomics for the detection of recombinant growth hormone doping control. J. Sep. Sci. 34(24), 3493-3501 (2011).
24. Kieken F, Pinel G, Antignac J-P et al. Generation and processing of urinary and plasmatic metabolomic fingerprints to reveal an illegal administration of recombinant equine growth hormone from LC-HRMS measurements. Metabolomics 7(1), 84-93 (2011).
25. Kieken F, Pinel G, Antignac JP et al. Development of a metabonomic approach based on LC-ESI-HRMS measurements for profiling of metabolic changes induced by recombinant equine growth hormone in horse urine. Anal. Bioanal. Chem. 394(8), 2119-2128 (2009).
26. Wilson ID, Nicholson JK, Castro-Perez J et al. High resolution "ultra performance" liquid chromatography coupled to oa-TOF mass spectrometry as a tool for differential metabolic pathway profiling in functional genomic studies. J. Proteome Res. 4(2), 591-598 (2005).
27. Mohamed R, Varesio E, Ivosev G, Burton L, Bonner R, Hopfgartner G. Comprehensive analytical strategy for biomarker identification based on liquid chromatography coupled to mass spectrometry and new candidate confirmation tools. Anal. Chem. 81(18), 7677-7694 (2009).
28. Veselkov KA, Vingara LK, Masson P et al. Optimized preprocessing of ultra-performance liquid chromatography-mass spectrometry urinary metabolic profiles for improved information recovery. Anal. Chem. 83(15), 5864-5872 (2011).
29. Kamleh MA, Ebbels TM, Spagou K, Masson P, Want EJ. Optimizing the use of quality control samples for signal drift correction in large-scale urine metabolic profiling studies. Anal. Chem. 84(6), 2670-2677 (2012).
30. Peters RJ, Oosterink JE, Stolker AA, Georgakopoulos C, Nielen MW. Generic sample preparation combined with high-resolution liquid chromatography-time-of- flight mass spectrometry for unification of urine screening in doping-control laboratories. Anal. Bioanal. Chem. 396(7), 2583-982598 (2010).
31. Sangster TP, Wingate JE, Burton L, Teichert F, Wilson ID. Investigation of analytical variation in metabonomic analysis using liquid chromatography-mass spectrometry. Rapid Commun. Mass Spectrom. 21(18), 2965-2970 (2007).
32. Smith CA, Want EJ, O'Maille G, Abagyan R, Siuzdak G. XCMS: processing mass spectrometry data for metabolite profiling using nonlinear peak alignment, matching, and identification. Anal. Chem. 78(3), 779-787 (2006).
33. Roux A, Xu Y, Heilier J-FO et al. Annotation of the human adult urinary metabolome and metabolite identification using ultra high performance liquid chromatography coupled to a linear quadrupole ion trap-orbitrap mass spectrometer. Anal. Chem. 84(15), 6429-6437 (2012).
34. KEGG Pathway Database.www.genome.jp/kegg/pathway.html
35. METLIN Metabolite Database.http://metlin.scripps.edu
36. HumanCyc: Encyclopedia of Homo sapiens Genes and Metabolism.http:// humancyc.org
37. The Human Metabolome Database.www.hmdb.ca
38. The DrugBank database.www.drugbank.ca
39. R Development Core Team. R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing, Vienna, Austria (2005).
40. Eriksson L, Johansson E, Kettaneh-Wold N, Trygg J, Wikström C, Wold S. Multi- and Megavariate Data Analysis, Part 2, Advanced Applications and Method Extensions. MKS Umetrics AB, Umeå, Sweden (2006).
41. Yang H, Amft M, Grundwurmer JM, Li X, Grotemeyer J. Primary structures of proteins characterized by proteinase K digestion and matrix-assisted laser desorption/ionization mass spectrometry. J. Pept. Res. 50(5), 402-406 (1997).
42. Petsch D, Deckwer WD, Anspach FB. Proteinase K digestion of proteins improves detection of bacterial endotoxins by the Limulus amebocyte lysate assay: application for endotoxin removal from cationic proteins. Anal. Biochem. 259(1), 42-47 (1998).
43. Petrotchenko EV, Serpa JJ, Hardie DB et al. Use of proteinase K nonspecific digestion for selective and comprehensive identification of interpeptide cross-links: application to prion proteins. Mol. Cell. Proteomics 11(7), M111.013524 (2012).
44. Garcia P, Paris AC, Gil J, Popot MA, Bonnaire Y. Analysis of b-agonists by HPLC/ESI-MS(n) in horse doping control. Biomed. Chromatogr. 25(1-2), 147-154 (2011).
45. Alzweiri M, Watson DG, Robertson C, Sills GJ, Parkinson JA. Comparison of different water-miscible solvents for the preparation of plasma and urine samples in metabolic profiling studies. Talanta 74(4), 1060-1065 (2008).
46. Michopoulos F, Lai L, Gika H, Theodoridis G, Wilson I. UPLC-MS-based analysis of human plasma for metabonomics using solvent precipitation or solid phase extraction. J. Proteome Res. 8(4), 2114-2121 (2009).
47. Wynne PM, Batty DC, Vine JH, Simpson NJK. Approaches to the solid-phase extraction of equine urine. Chromatographia 59(0), S51-S60 (2004).
48. Lin C, Wu H, Tjeerdema R, Viant M. Evaluation of metabolite extraction strategies from tissue samples using NMR metabolomics. Metabolomics 3(1), 55-67 (2007).
49. Von Horsten HH. Current strategies and techniques for the analysis of low-abundance proteins and peptides from complex samples. Curr. Anal. Chem. 2(2), 129-138 (2006).
50. Trygg J, Holmes E, Lundstedt T. Chemometrics in metabonomics. J. Proteome Res. 6(2), 469-479 (2007).
51. Parsons HM, Ekman DR, Collette TW, Viant MR. Spectral relative standard deviation: a practical benchmark in metabolomics. Analyst 134(3), 478-485 (2009).
52. Masson P, Alves AC, Ebbels TM, Nicholson JK, Want EJ. Optimization and evaluation of metabolite extraction protocols for untargeted metabolic profiling of liver samples by UPLC-MS. Anal. Chem. 82(18), 7779-7786 (2010).
53. Crews B, Wikoff WR, Patti GJ et al. Variability analysis of human plasma and cerebral spinal fluid reveals statistical significance of changes in mass spectrometry-based metabolomics data. Anal. Chem. 81(20), 8538-8544 (2009).
54. Sumner L, Amberg A, Barrett D et al. Proposed minimum reporting standards for chemical analysis. Metabolomics (3), 211-221 (2007).
55. Kiss A, Lucio M, Fildier A, Buisson C, Schmitt-Kopplin P, Cren-Olive C. Doping control using high and ultra-high resolution mass spectrometry based non-targeted metabolomics-a case study of salbutamol and budesonide abuse. PLoS ONE 8(9), e74584 (2013).
56. Bruce SJ, Tavazzi I, Parisod V, Rezzi S, Kochhar S, Guy PA. Investigation of human blood plasma sample preparation for performing metabolomics using ultrahigh performance liquid chromatography-mass spectrometry. Anal. Chem. 81(9), 3285-3296 (2009).
57. Lorenz MA, Burant CF, Kennedy RT. Reducing time and increasing sensitivity in sample preparation for adherent mammalian cell metabolomics. Anal. Chem. 83(9), 3406-3414 (2011).
58. Want EJ, Wilson ID, Gika H et al. Global metabolic profiling procedures for urine using UPLC-MS. Nat. Protoc. 5(6), 1005-1018 (2010).
59. Bouatra S, Aziat F, Mandal R et al. The human urine metabolome. PLoS ONE 8(9), e73076 (2013).